pubrio
BioNTech SE logo

BioNTech SE

Privately Held
biontech.com
生物技術研究5,000+ employeesFounded 2008🇩🇪 德國

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html 🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html 🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

成立年份
2008
員工
5,000+
行業
生物技術研究
公司類型
Privately Held
股票
nasdaq: BNTX
總部
🇩🇪Mainz, Rhineland-Palatinate (+6)
專長
製藥產業生物技術醫療保健生物技術研究
5 / 11
活躍市場
0
新市場
信心度
大多為早期訊號
-12%
動能
對比上一週期
41 / 100
擴張評分
發展中
階段3探索中7投入中1進入中
15 個訊號 · 過去 90 日

全球擴張

即時
CNUSGB
階段
探索中投入中進入中營運中
+8個市場已鎖定
已顯示 11 個中的 3 個

解鎖市場時間軸與訊號動態

活動脈搏

全新 合作夥伴 活動 — 剛出現 2 個新訊號。

過去 90 日
招聘
12
招聘
市場推廣與公關
0
無活動
產品與技術
2已結束
產品發布
+2個類別已鎖定
已顯示 5 個中的 3 個

市場進入時間軸

此公司進入各市場的次序 — 由最舊至最新

1
🇺🇸US第 1st 個進入的市場 · 2020推進中
投入中
24 個訊號投入中 階段
2
🇬🇧GB第 2nd 個進入的市場 · 2021推進中
投入中
13 個訊號投入中 階段
3
🇨🇳CN第 3rd 個進入的市場 · 2021推進中
進入中
39 個訊號進入中 階段
+8個市場已鎖定
已顯示 11 個中的 3 個
目前階段進入中落地佈署
信心度38%
開始追蹤於2020首個訊號

近期訊號

人手擴充🇨🇳 CN昨日

34 active postings

招聘🇦🇺 AU2星期前

Microbiological Analyst QC

註冊以查看完整訊號動態

值得了解

關於 BioNTech SE 的常見問題

關於 BioNTech SE 業務、市場及增長訊號的快速解答。

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html 🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html 🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。